STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] DoubleVerify Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

DoubleVerify (DV): Schedule 13G/A (Amendment No. 3) reports that affiliates of Providence Equity collectively beneficially own 18,479,822 shares of DoubleVerify common stock, representing 11.5% of the class. Percentages are based on 161,107,214 shares outstanding as of October 31, 2025, as disclosed in the company’s Form 10-Q.

The filing lists Providence VII U.S. Holdings L.P. (18,173,777 shares), Providence Butternut Co‑Investment L.P. (117,131 shares), and individuals including R. Davis Noell (40,658 shares), J. David Phillips (30,720 shares), Andrew A. Tisdale (2,500 shares via trust), and Michael J. Dominguez (115,036 shares). The reporting persons filed jointly under Rule 13d‑1(k) and include Providence Equity GP VII‑A L.P., which may be deemed to beneficially own certain shares through control relationships. The stated event date is September 30, 2025.

Positive
  • None.
Negative
  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: All percentages calculated in this Schedule 13G are based upon an aggregate of 161,107,214 shares of Common Stock outstanding as of October 31, 2025, as reported in the Issuer's quarterly report on Form 10-Q, as filed with the Securities and Exchange Commission on November 7, 2025.


SCHEDULE 13G



Providence VII U.S. Holdings L.P.
Signature:/s/ Sarah N. Conde
Name/Title:By: Providence Equity GP VII-A L.P., its general partner; PEP VII-A International Ltd., its general partner; Sarah N. Conde, GC, MD & CCO
Date:11/12/2025
Providence Equity GP VII-A L.P.
Signature:/s/ Sarah N. Conde
Name/Title:By: PEP VII-A International Ltd., its general partner; Sarah N. Conde, GC, MD & CCO
Date:11/12/2025
Providence Butternut Co-Investment L.P.
Signature:/s/ Sarah N. Conde
Name/Title:By: Providence Equity GP VII-A L.P., its general partner; PEP VII-A International Ltd., its general partner; Sarah N. Conde, GC, MD & CCO
Date:11/12/2025
R. Davis Noell
Signature:/s/ R. Davis Noell
Name/Title:R. Davis Noell
Date:11/12/2025
J. David Phillips
Signature:/s/ J. David Phillips
Name/Title:J. David Phillips
Date:11/12/2025
Karim A. Tabet
Signature:/s/ Karim A. Tabet
Name/Title:Karim A. Tabet
Date:11/12/2025
Andrew A. Tisdale
Signature:/s/ Andrew A. Tisdale
Name/Title:Andrew A. Tisdale
Date:11/12/2025
Michael J. Dominguez
Signature:/s/ Michael J. Dominguez
Name/Title:Michael J. Dominguez
Date:11/12/2025
Doubleverify Hldgs Inc

NYSE:DV

DV Rankings

DV Latest News

DV Latest SEC Filings

DV Stock Data

1.69B
141.40M
0.68%
102.75%
5.77%
Software - Application
Services-computer Programming, Data Processing, Etc.
Link
United States
NEW YORK